HESTERBIOHester Biosciences Limited
Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-07-19 (delayed ~30 min in market hours)
₹2,447.80
▲ 0.42%Excellent
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)2,030.40
P/E36.49
P/B5.64
PEG0.04
ROE %16.56
ROCE %13.90
Debt / Equity0.53
EPS65.41
Revenue Growth %40.30
Profit Growth %968.70
Dividend Yield %0.75
Promoter Holding %68.79
FII Holding %0.27
DII Holding %—
Beta0.49
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Breakout with Volume | LONG | 88% | ₹2,545.00 | ₹2,110.00 | ₹3,415.00 | 2.00 |
BUYConfidence 82%
- • Revenue growth: 40.3% YoY
- • Profit growth: 968.7% YoY
- • ROE: 16.6%
- • RSI: 66
- • MACD: bullish
- • Price vs EMA21: above
- • Breakout with Volume signal (confidence 88%)
Bull case
- • Revenue growth: 40.3% YoY
- • Profit growth: 968.7% YoY
- • ROE: 16.6%
- • RSI: 66
Bear case
- • Volume: 0.3x 20-day average
- • Max drawdown (1y): 42%
Key risks
- • Volume: 0.3x 20-day average
- • Max drawdown (1y): 42%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹2,447.80
Stop Loss
₹2,124.43
risk 13.2%
Target 1 (1.5R)
₹2,932.85
+19.8%
Target 2 (3R)
₹3,417.90
+39.6%
Support (20d)
₹2,058.27
Resistance (52w)
₹2,660.00
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹323.37/share
ATR (volatility)
₹129.35
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹129.35). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
83
Technical
78
Momentum
96
Risk (safety)
51